Gene (accession No) | Upregulated (fold increase) | Downregulated (fold decrease) | Regulation |
---|---|---|---|
Values represent the mean up- or downregulation of all experiments in each patient. | |||
*4 (6) indicates 4 of 6 patients regulated differentially. | |||
M, median; MAPK p38, mitogen activated protein kinase p38; IFGR, interferon γ receptor; TSP2, thrombospondin 2; FAST kinase, Fas activated serine/threonine kinase. | |||
p21-rac1; ras related protein TC25 (M29870, M31467) | 2.4 | ↑ 4 (6)* | |
3.4 | |||
3.0 | |||
4.5 | |||
(M=3.3) | |||
MAPK p38 (L35253, L35263) | 2.8 | ↑ 3 (6) | |
3.3 | |||
3.5 | |||
(M=3.2) | |||
IFGR (A09781) | 3.7 | ↑ 3 (6) | |
4.0 | |||
2.8 | |||
(M=3.5) | |||
TSP2 (L12350) | 8.3 | ↓ 3 (6) | |
8.7 | |||
9.8 | |||
(M=8.9) | |||
p53 cellular tumour antigen (M14694, M14695) | 2.5 | ↓ 3 (6) | |
3.2 | |||
28.2 | |||
(M=11.3) | |||
FAST kinase (X86779) | 4.6 | ↓ 3 (6) | |
9.9 | |||
2.5 | |||
(M=5.7) |